Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses.

Autor: Hocke J; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Krauth J; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Krause C; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Gerlach S; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Warnemünde N; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., Affeldt K; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany., van Beek N; Department of Dermatology, Allergology and Venerology, University Hospital Schleswig-Holstein/University of Lübeck, Lübeck, Germany., Schmidt E; Department of Dermatology, Allergology and Venerology, University Hospital Schleswig-Holstein/University of Lübeck, Lübeck, Germany.; Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany., Voigt J; Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 28; Vol. 14, pp. 1111172. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rechnerunterstützte Polarographie.

Autor: Ebel, S., Hocke, J., Richter, M., Surmann, P.

Publikováno v: Fresenius' Zeitschrift für Analytische Chemie; 1980, Vol. 300 Issue 3, p200-203, 4p

LBA20_PR - gastrointestinal tumours, colorectal Nintedanib plus best supportive care (BSC) versus placebo plus BSC for the treatment of patients (pts) with colorectal cancer (CRC) refractory to standard therapies: Results of the phase III LUME-colon 1 study

Autor: Van Cutsem, E., Yoshino, T., Lenz, H.-J., Lonardi, S., Falcone, A., Limon, M.L., Saunders, M.P., Sobrero, A., Maiello, E., Park, Y.S., Monteagudo, R. Ferreiro, Hong, Y.S., Tomasek, J., Taniguchi, H., Ciardiello, F., Hocke, J., Oum'hamed, Z., Vlassak, S., Studeny, M., Tabernero, J.

Publikováno v: In Annals of Oncology 1 October 2016 27 Supplement 6:vi559-vi559

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma.

Autor: Yen CJ; Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Kim TY; Seoul National University Hospital, Seoul, Republic of Korea., Feng YH; Chi Mei Medical Center, Yongkang, Tainan, Taiwan., Chao Y; Taipei Veterans General Hospital, Taipei, Taiwan., Lin DY; Chang Gung Memorial Hospital & Chang Gung University, College of Medicine, Taoyuan, Taiwan., Ryoo BY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Huang DC; Boehringer Ingelheim Taiwan Limited, Taipei, Taiwan., Schnell D; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Hocke J; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany., Loembé AB; Boehringer Ingelheim B.V., Alkmaar, the Netherlands., Cheng AL; National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University Cancer Center, Taipei, Taiwan.

Publikováno v: Liver cancer [Liver Cancer] 2018 May; Vol. 7 (2), pp. 165-178. Date of Electronic Publication: 2018 Mar 15.